Rashmi Bhakuni

About Rashmi Bhakuni

Rashmi Bhakuni, With an exceptional h-index of 4 and a recent h-index of 4 (since 2020), a distinguished researcher at Indian Institute of Technology Gandhinagar, specializes in the field of DNA Damage Response, Merkel Cell Carcinoma, Translational Immuno-Oncology, Cancer Chemical Biology.

His recent articles reflect a diverse array of research interests and contributions to the field:

1018 A transcriptional signature shared by circulating cancer-specific CD8 T cells

Inhibition potentiates immunogenicity in Merkel cell carcinoma: a promising approach to overcome resistance to anti-PD-1 immunotherapy

848 Inhibition of ATR augments immunogenicity in merkel cell carcinoma: A promising approach to address resistance to anti-PD-1 immunotherapy

An intratumoral STING agonist-mediated clinical response in PD-L1-refractory MCC via an unexpected mechanism of action

DNA Damage Response Inhibitors as Potentiators of Radiation and Immunogenicity in Merkel Cell Carcinoma

LB820 ATR inhibition for potentiation of immunogenicity and cell death in Merkel Cell Carcinoma refractory to PD-1 pathway blockade

Intersection of two checkpoints: could inhibiting the DNA damage response checkpoint rescue immune checkpoint-refractory cancer?

Characterization of SPK 98, a Torin2 analog, as ATR and mTOR dual kinase inhibitor

Rashmi Bhakuni Information

University

Position

Research Scholar

Citations(all)

68

Citations(since 2020)

59

Cited By

26

hIndex(all)

4

hIndex(since 2020)

4

i10Index(all)

4

i10Index(since 2020)

4

Email

University Profile Page

Google Scholar

Rashmi Bhakuni Skills & Research Interests

DNA Damage Response

Merkel Cell Carcinoma

Translational Immuno-Oncology

Cancer Chemical Biology

Top articles of Rashmi Bhakuni

Title

Journal

Author(s)

Publication Date

1018 A transcriptional signature shared by circulating cancer-specific CD8 T cells

Saumya Jani

Thomas Pulliam

Nandita Kumar

Ana Jojic

Rashmi Bhakuni

...

2023/11/1

Inhibition potentiates immunogenicity in Merkel cell carcinoma: a promising approach to overcome resistance to anti-PD-1 immunotherapy

Journal of Investigative Dermatology

Rashmi Bhakuni

Peter H Goff

Jung Hyun Lee

Thomas Pulliam

Shira Tabachnick-Cherny

...

2022/10/1

848 Inhibition of ATR augments immunogenicity in merkel cell carcinoma: A promising approach to address resistance to anti-PD-1 immunotherapy

Journal of Investigative Dermatology

R Bhakuni

P Goff

JH Lee

T Pulliam

S Tabachnick-Cherny

...

2022/8/1

An intratumoral STING agonist-mediated clinical response in PD-L1-refractory MCC via an unexpected mechanism of action

Journal of Investigative Dermatology

Thomas H Pulliam

Rashmi Bhakuni

Saumya Jani

Kimberly Smythe

Brandon Seaton

...

2022/10/1

DNA Damage Response Inhibitors as Potentiators of Radiation and Immunogenicity in Merkel Cell Carcinoma

International Journal of Radiation Oncology, Biology, Physics

PH Goff

R Bhakuni

T Pulliam

S Tabachnick-Cherny

CD Morningstar

...

2021/11/1

LB820 ATR inhibition for potentiation of immunogenicity and cell death in Merkel Cell Carcinoma refractory to PD-1 pathway blockade

Journal of Investigative Dermatology

R Bhakuni

P Goff

J Lee

T Pulliam

S Cherny

...

2021/9/1

Intersection of two checkpoints: could inhibiting the DNA damage response checkpoint rescue immune checkpoint-refractory cancer?

Peter H Goff

Rashmi Bhakuni

Thomas Pulliam

Jung Hyun Lee

Evan T Hall

...

2021/7/8

Characterization of SPK 98, a Torin2 analog, as ATR and mTOR dual kinase inhibitor

Bioorganic & Medicinal Chemistry Letters

Rashmi Bhakuni

Althaf Shaik

Bhanu Priya

Sivapriya Kirubakaran

2020/12/1

MDC1 depletion promotes cisplatin induced cell death in cervical cancer cells

BMC Research Notes

Neeru Singh

Rashmi Bhakuni

Dimple Chhabria

Sivapriya Kirubakaran

2020/12

See List of Professors in Rashmi Bhakuni University(Indian Institute of Technology Gandhinagar)

Co-Authors

academic-engine